GSK grows pipeline with 35Pharma takeover, Frontier deal GSK CEO Luke Miels signs a pair of pipeline-expanding deals, and the first acquisition on his watch, as the group prepares for a looming patent cliff.

#GSK #35Pharma #pulmonaryarterialhypertension #PAH #heartfailure #FrontierBio #pharmalicensing #LukeMiels #siRNAtherapeutics #FrontierBiotech #HS235 #phase1 #clinicaltrials #heartfailurewithpreservedejectionfraction #HFpEF #bestinclasstherapy #activindirectedtherapy #INDstudies
zurl.co/9nkDQ

More Acquisitions: #QuantumeMotion > #SKVTechnology; #Salesforce > #Momentum; #Scale > #Reload; #Brink’s > #NCRAtleos

Agreed Acquisitions: #Arcellx > #GileadSciences; #DubaiAerospaceEnterprise > #MacquarieAirFinance; #Engie > #UKPowerNetworks; #GSK > #35Pharma; #Uber > #SpotHero

GSK grows pipeline with 35Pharma takeover, Frontier deal GSK CEO Luke Miels signs a pair of pipeline-expanding deals, and the first acquisition on his watch, as the group prepares for a looming patent cliff.

The steady stream of M&A #deals in #pharma this year has continued with the news that #GSK has agreed to buy #Canada's #35Pharma and its drug candidate for #pulmonaryhypertension (PH) for $950 million.